Intolerance Complex
Intolerance Complex, licence 80042339: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Enzyme Science
- NPN or DIN-HM
- 80042339
- Status
- Active licence
- Licence date
- 16 May 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E ,6E ,10E ,14E ,18E ,22E ,26E , 30E ,34E )-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Microorganismes CoQ10 - Cellule entière pour biosynthèse | 5.0 mg | Not calculated |
| Beta-fructofuranosidase Source : Saccharomyces cerevisiae - cellule entière Potency : 1.0 mg | 75.0 FCC SU | Not calculated |
| Beta-fructofuranosidase Source : Invertase Potency : 1.0 mg | 75.0 FCC SU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma reesei - en entier Potency : 2.0 mg | 200.0 FCC CU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Aspergillus niger - En entier Potency : 2.0 mg | 200.0 FCC CU | Not calculated |
| Protéase bactérien Source : Bacillus subtilis - cellule entière Potency : 66.0 mg | 2350.0 FCC PU | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger - En entier Potency : 2.0 mg | 400.0 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier Potency : 2.0 mg | 400.0 FCC LU | Not calculated |
| Adenosine 5'-(tetrahydrogen triphosphate) Source : Adénosine triphosphate | 1.0 mg | Not calculated |
Non-medicinal ingredients
Citrate de magnésium, triglycérides à chaînes moyennes, Eau purifiée, cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Protease is a digestive aid. Protease helps digest proteins. Alpha-galactosidase helps reduce gas production/flatulence following a meal rich in fermentable carbohydrates (such as vegetables, pulses/legumes/beans and whole grains). Alpha-galactosidase helps prevent gastrointestinal intolerance of oligosaccharides/fermentable carbohydrates. Digestive enzymes.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80042339
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.